Forging New Paths In Cancer Diagnostics
HistoIndex is partnering with the University of Malaya and Pathomics Health to roll out an integrative diagnostics platform for the holistic analysis of patient tumor biopsies.
HistoIndex is partnering with the University of Malaya and Pathomics Health to roll out an integrative diagnostics platform for the holistic analysis of patient tumor biopsies.
Laennec® has achieved its first regulated in vitro diagnostics (IVD) product status with the issuance of a Health Sciences Authority (HSA) Class A licence.